Skip to main content
. 2016 Oct 1;32(8):555–562. doi: 10.1089/jop.2015.0148

Table 4.

Summary of Incidence of Hyperemia by Treatment Group and Time point—All Stages (%)

  Screening Day4 Day1 Day 1-predose Day 1-postdose Day 14 Day 28
Placebo 8.5 3.4 1.7 3.4 0.6 3.5 3.8
50 mcg 0.0 0.0 0.0 0.0 0.0 0.0 0.0
100 mcg 5.9 5.9 0.0 0.0 0.0 0.0 0.0
200 mcg 0.0 0.0 0.0 0.0 2.0 1.0 0.0
500 mcg 14.7 11.8 12.5 11.8 n/a 12.7 12.1